A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
Synthetic influenza seeds
2013
Science-Business eXchange
Preserved Fulltext
An international team led by Novartis AG and the J. Craig Venter Institute has improved the speed and accuracy of seed influenza virus production for large-scale vaccine manufacture. 1 Adoption of the platform could shave weeks off the time needed to generate vaccine in response to a pandemic.
doi:10.1038/scibx.2013.509
fatcat:i7z26jsddbazlksfiywntf53pm